Drug Shortage Report for Technetium Tc 99m TSC
Report ID | 14396 |
Drug Identification Number | |
Brand name | Thallous Chloride TI 201 Injection |
Common or Proper name | Thallous Chloride TI 201 Injection |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | |
Active Ingredient(s) | Thallous Chloride (TI 201) |
Strength(s) | 1 mCi/mL |
Dosage form(s) | Solution |
Route of administration | Intravenous |
Packaging size | glass vial |
ATC code | V09GX |
ATC description | Cardiovascular system |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-06-27 |
Estimated end date | 2017-06-30 |
Actual end date | 2017-06-30 |
Shortage status | Resolved |
Updated date | 2017-07-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-07-04 | French | Compare |
v6 | 2017-07-04 | English | Compare |
v5 | 2017-07-01 | English | Compare |
v4 | 2017-06-30 | French | Compare |
v3 | 2017-06-30 | English | Compare |
v2 | 2017-06-29 | French | Compare |
v1 | 2017-06-29 | English | Compare |
Showing 1 to 7 of 7